NLRP3 Inflammasomes: Central Players and Therapeutic Targets in Alzheimer's disease Pathogenesis

By targeting the activation or inactivation of the NLRP3 inflammasome, it could be possible to reveal the pathophysiology of AD from a new perspective and provide a novel strategy for its prevention and treatment.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70855_104829
Primary Topic
Inflammasome and immune disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

NLRP3 Inflammasomes: Central Players and Therapeutic Targets in Alzheimer's disease Pathogenesis

Chirag Sharma
Alzheimer s & Dementia
Inflammasome and immune disorders
article

NLRP3 Inflammasomes: Central Players and Therapeutic Targets in Alzheimer's disease Pathogenesis

Chirag Sharma
article en

Abstract

By targeting the activation or inactivation of the NLRP3 inflammasome, it could be possible to reveal the pathophysiology of AD from a new perspective and provide a novel strategy for its prevention and treatment.

Alzheimer s & DementiaVol. 21(S1)
J.C. Bose University of Science & Technology, YMCA (IN)
Openalex Percentile: Top 36%
Inflammasome and immune disorders
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

NLRP3 Inflammasomes: Central Players and Therapeutic Targets in Alzheimer's disease Pathogenesis — Chirag Sharma · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS